State NY
Clinical Trials in New York
Recruiting clinical trials with at least one study location in New York. Data updated daily from ClinicalTrials.gov.
Top Conditions in New York
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
NCT07064200 N/A
Recruiting
TAP Block Timing Study
Condition
Bariatric or General Abdominal Surgeries
Enrollment
150 pts
Location
United States
Sponsor
Weill Medical College of Corne
NCT00230165 N/A
Recruiting
The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red B...
Condition
Glanzmann Thrombasthenia
Enrollment
60 pts
Location
United States
Sponsor
Rockefeller University
NCT07190807 N/A
Recruiting
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent...
Condition
Chronic Pain
Enrollment
70 pts
Location
United States
Sponsor
Boston Scientific Corporation
NCT00231400 N/A
Recruiting
Pompe Disease Registry Protocol
Condition
Glycogen Storage Disease Type II
Enrollment
2,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT05676099 N/A
Recruiting
TSC Biosample Repository and Natural History Database
Condition
Tuberous Sclerosis
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
National Tuberous Sclerosis As
NCT00097292 N/A
Recruiting
TrialNet Pathway to Prevention of T1D
Condition
Diabetes Mellitus, Type 1
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
University of South Florida
NCT05491512 Phase 2
Recruiting
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People...
Condition
HPV
Enrollment
121 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05723107 Phase 1
Recruiting
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
Condition
Pancreatic Cancer
Enrollment
15 pts
Location
United States
Sponsor
NYU Langone Health
NCT03686124 Phase 1, Phase 2
Recruiting
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in R...
Condition
Refractory Cancer
Enrollment
375 pts
Location
United States, Germany
Sponsor
Immatics US, Inc.
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06269705 Phase 3
Recruiting
ZILRETTA in Subjects With Shoulder Osteoarthritis
Condition
Glenohumeral Osteoarthritis
Enrollment
150 pts
Location
United States
Sponsor
Pacira Pharmaceuticals, Inc
NCT05999994 Phase 2
Recruiting
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for ...
Condition
Neoplasms
Enrollment
105 pts
Location
United States, Australia, Belgium
Sponsor
Eli Lilly and Company
NCT06936566 Phase 2
Recruiting
MAGIC Ruxolitinib for aGVHD
Condition
Acute Graft-versus-host Disease
Enrollment
98 pts
Location
United States
Sponsor
John Levine
NCT06950983 N/A
Recruiting
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adu...
Condition
Cancer in Adolescence
Enrollment
120 pts
Location
United States
Sponsor
Columbia University
NCT07046260 N/A
Recruiting
Prospective Study to Assess a Diagnostic Aid for Cancer
Condition
Cancer
Enrollment
1,650 pts
Location
United States
Sponsor
Harbinger Health
NCT05515224 N/A
Recruiting
5-Cog 2.0: A Pragmatic Clinical Trial
Condition
Dementia
Enrollment
6,600 pts
Location
United States
Sponsor
Albert Einstein College of Med
NCT05134779 N/A
Recruiting
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immun...
Condition
Breast Cancer
Enrollment
400 pts
Location
United States
Sponsor
Weill Medical College of Corne
NCT06462183 Phase 1
Recruiting
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Ade...
Condition
Adenoid Cystic Carcinoma
Enrollment
105 pts
Location
United States, Canada
Sponsor
Rgenta Therapeutics Inc
NCT02790983 N/A
Recruiting
Primary Tumor Research and Outcomes Network
Condition
Spinal Column Tumor
Enrollment
1,350 pts
Location
United States, Australia, Canada
Sponsor
AO Innovation Translation Cent
NCT06854224 Phase 2
Recruiting
Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial
Condition
Suicide Risk
Enrollment
30 pts
Location
United States
Sponsor
Marianne Goodman
NCT06776783 Phase 3
Recruiting
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syn...
Condition
Respiratory Distress Syndrome
Enrollment
520 pts
Location
United States
Sponsor
Aerogen Pharma Limited
NCT04777994 Phase 1
Recruiting
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumo...
Condition
Advanced Solid Tumor Cancer
Enrollment
248 pts
Location
United States, France, Israel
Sponsor
Calico Life Sciences LLC
NCT06859788 Phase 3
Recruiting
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
Condition
Meniere's Disease
Enrollment
200 pts
Location
United States
Sponsor
Sound Pharmaceuticals, Incorpo
NCT05240651 N/A
Recruiting
Change in Stroke Volume Index After Diuresis for Patients With Decompensated Hea...
Condition
Acute Decompensated Heart Failure
Enrollment
50 pts
Location
United States
Sponsor
NYU Langone Health